Literature DB >> 20649590

Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.

M J Hatfield1, L Tsurkan, J L Hyatt, X Yu, C C Edwards, L D Hicks, R M Wadkins, P M Potter.   

Abstract

BACKGROUND AND
PURPOSE: Carboxylesterases (CEs) metabolize a wide range of xenobiotic substrates including heroin, cocaine, meperidine and the anticancer agent CPT-11. In this study, we have purified to homogeneity human liver and intestinal CEs and compared their ability with hydrolyse heroin, cocaine and CPT-11. EXPERIMENTAL APPROACH: The hydrolysis of heroin and cocaine by recombinant human CEs was evaluated and the kinetic parameters determined. In addition, microsomal samples prepared from these tissues were subjected to chromatographic separation, and substrate hydrolysis and amounts of different CEs were determined. KEY
RESULTS: In contrast to previous reports, cocaine was not hydrolysed by the human liver CE, hCE1 (CES1), either as highly active recombinant protein or as CEs isolated from human liver or intestinal extracts. These results correlated well with computer-assisted molecular modelling studies that suggested that hydrolysis of cocaine by hCE1 (CES1), would be unlikely to occur. However, cocaine, heroin and CPT-11 were all substrates for the intestinal CE, hiCE (CES2), as determined using both the recombinant protein and the tissue fractions. Again, these data were in agreement with the modelling results. CONCLUSIONS AND IMPLICATIONS: These results indicate that the human liver CE is unlikely to play a role in the metabolism of cocaine and that hydrolysis of this substrate by this class of enzymes is via the human intestinal protein hiCE (CES2). In addition, because no enzyme inhibition is observed at high cocaine concentrations, potentially this route of hydrolysis is important in individuals who overdose on this agent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20649590      PMCID: PMC2958638          DOI: 10.1111/j.1476-5381.2010.00700.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  cDNA cloning, characterization and stable expression of novel human brain carboxylesterase.

Authors:  M Mori; M Hosokawa; Y Ogasawara; E Tsukada; K Chiba
Journal:  FEBS Lett       Date:  1999-09-10       Impact factor: 4.124

2.  Hydrolysis of cocaine in human plasma by cholinesterase.

Authors:  D J Stewart; T Inaba; B K Tang; W Kalow
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

3.  Purification and cloning of a broad substrate specificity human liver carboxylesterase that catalyzes the hydrolysis of cocaine and heroin.

Authors:  E V Pindel; N Y Kedishvili; T L Abraham; M R Brzezinski; J Zhang; R A Dean; W F Bosron
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

4.  Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzil.

Authors:  Christopher D Fleming; Sompop Bencharit; Carol C Edwards; Janice L Hyatt; Lyudmila Tsurkan; Feng Bai; Charles Fraga; Christopher L Morton; Escher L Howard-Williams; Philip M Potter; Matthew R Redinbo
Journal:  J Mol Biol       Date:  2005-09-09       Impact factor: 5.469

5.  Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases.

Authors:  Randy M Wadkins; Janice L Hyatt; Xin Wei; Kyoung Jin P Yoon; Monika Wierdl; Carol C Edwards; Christopher L Morton; John C Obenauer; Komath Damodaran; Paul Beroza; Mary K Danks; Philip M Potter
Journal:  J Med Chem       Date:  2005-04-21       Impact factor: 7.446

6.  Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.

Authors:  Janice L Hyatt; Vanessa Stacy; Randy M Wadkins; Kyoung Jin P Yoon; Monika Wierdl; Carol C Edwards; Matthias Zeller; Allen D Hunter; Mary K Danks; Guy Crundwell; Philip M Potter
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

7.  Cellular localization domains of a rabbit and a human carboxylesterase: influence on irinotecan (CPT-11) metabolism by the rabbit enzyme.

Authors:  P M Potter; J S Wolverton; C L Morton; M Wierdl; M K Danks
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

8.  Rapid stereoselective hydrolysis of (+)-cocaine in baboon plasma prevents its uptake in the brain: implications for behavioral studies.

Authors:  S J Gatley; R R MacGregor; J S Fowler; A P Wolf; S L Dewey; D J Schlyer
Journal:  J Neurochem       Date:  1990-02       Impact factor: 5.372

9.  Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis.

Authors:  Hao-Jie Zhu; Kennerly S Patrick; Hong-Jie Yuan; Jun-Sheng Wang; Jennifer L Donovan; C Lindsay DeVane; Robert Malcolm; Julie A Johnson; Geri L Youngblood; Douglas H Sweet; Taimour Y Langaee; John S Markowitz
Journal:  Am J Hum Genet       Date:  2008-05-15       Impact factor: 11.025

10.  Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.

Authors:  François Girardin; Katharina M Rentsch; Marc-André Schwab; Marco Maggiorini; Christiane Pauli-Magnus; Gerd A Kullak-Ublick; Peter J Meier; Karin Fattinger
Journal:  Clin Pharmacol Ther       Date:  2003-10       Impact factor: 6.875

View more
  21 in total

1.  Prediction and in vitro evaluation of selected protease inhibitor antiviral drugs as inhibitors of carboxylesterase 1: a potential source of drug-drug interactions.

Authors:  Jenna A Rhoades; Yuri K Peterson; Hao-Jie Zhu; David I Appel; Charles A Peloquin; John S Markowitz
Journal:  Pharm Res       Date:  2011-12-09       Impact factor: 4.200

Review 2.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

3.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Authors:  Shuqi Xie; Abdolsamad Borazjani; M Jason Hatfield; Carol C Edwards; Philip M Potter; Matthew K Ross
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

Review 4.  Carboxylesterase inhibitors.

Authors:  M Jason Hatfield; Philip M Potter
Journal:  Expert Opin Ther Pat       Date:  2011-05-24       Impact factor: 6.674

Review 5.  Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.

Authors:  Upendra A Argikar; Philip M Potter; J Matthew Hutzler; Punit H Marathe
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

6.  Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors.

Authors:  Randall J Binder; M Jason Hatfield; Liying Chi; Philip M Potter
Journal:  Eur J Med Chem       Date:  2018-02-19       Impact factor: 6.514

7.  Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon.

Authors:  J Allen Crow; Victoria Bittles; Katye L Herring; Abdolsamad Borazjani; Philip M Potter; Matthew K Ross
Journal:  Toxicol Appl Pharmacol       Date:  2011-11-04       Impact factor: 4.219

8.  Potent, Irreversible Inhibition of Human Carboxylesterases by Tanshinone Anhydrides Isolated from Salvia miltiorrhiza ("Danshen").

Authors:  M Jason Hatfield; Randall J Binder; Rowan Gannon; Ellie M Fratt; John Bowling; Philip M Potter
Journal:  J Nat Prod       Date:  2018-10-23       Impact factor: 4.050

9.  Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11).

Authors:  Shujuan Chen; Mei-Fei Yueh; Cyril Bigo; Olivier Barbier; Kepeng Wang; Michael Karin; Nghia Nguyen; Robert H Tukey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

10.  Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

Authors:  M Jason Hatfield; Lyudmila G Tsurkan; Janice L Hyatt; Carol C Edwards; Andrew Lemoff; Cynthia Jeffries; Bing Yan; Philip M Potter
Journal:  J Nat Prod       Date:  2013-01-03       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.